Pharmafile Logo
Pharmafocus logo
Advanced Search

Microba Life Sciences launches next-generation healthcare testing for gastrointestinal health

March 2, 2023
Medical Communications

Australian precision microbiome company Microba Life Sciences has launched its next-generation testing range for gastrointestinal health. MetaXplore has been relaunched …

News

Eli Lilly caps consumer insulin costs at $35

March 2, 2023
Medical Communications

Eli Lilly & Co has announced that it will cap out-of-pocket insulin costs at $35 per month, following a plea …

News

FDA panel backs GSK RSV vaccine ahead of approval

March 2, 2023
Medical Communications

Yesterday, GSK shared that an advisory committee from the FDA voted in support of its respiratory syncytial virus (RSV) vaccine …

News

Menopause Action Plan – How nutritional support can keep female employees at work

March 1, 2023
Business Services

Through simple nutrition and lifestyle changes HR managers could enable women to continue to thrive at work and pursue their …

News
Press release

Ten new companies enter BioInnovation Institute’s Venture Lab program

March 1, 2023
Business Services

COPENHAGEN, Denmark, March 1, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today …

News
Press release

Koa Health appoints Dr Anna Mandeville as UK Clinical Director and Leslie Norwalk to the Supervisory Board

March 1, 2023
Business Services

London, 1st March 2023: Koa Health, a leading global provider of digital mental healthcare solutions, today announces that Dr Anna …

Appointment

PureTech to Present at the Barclays Global Healthcare Conference

March 1, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …

News
Press release

NICE recommends more digital mental health therapies for NHS use

March 1, 2023
Medical Communications

Eight more digital therapies (DTx) for mental health disorders have been recommended by NICE for use by the NHS, following …

News

FDA approves Reata Pharmaceuticals’ first-in-class treatment for Friedreich’s Ataxia

March 1, 2023
Medical Communications

US-based Reata Pharmaceuticals has announced that its first-in-class treatment for Friedreich’s Ataxia (FA), Skyclarys, has been given FDA approval. This …

News

BioNxt Solutions signs clinical study agreement and commences clinical samples manufacture for Parkinson’s disease trial

March 1, 2023
Research and Development

BioNxt Solutions, a bioscience accelerator focused on next-generation drug formulations and delivery systems, has announced the finalisation of its comparative …

News

Sequana Medical shares positive results from phase 1 clinical trial

March 1, 2023
Research and Development

Sequana Medical has shared positive results from its phase 1 trial, CHIHUAHUA, assessing the safety and tolerability of a single …

News

Industrywide Survey Reveals Centralising Regulatory is Number One Priority for Medtech

March 1, 2023
Business Services

BARCELONA, Spain — 28 Feb. 2023 — New research shows a majority of medtech organizations are taking action to advance …

News
Press release

Ascelia Pharma meets major milestone with patient enrollment completion of Phase 3 Study for Orviglance, novel MRI contrast agent for patients with kidney impairment

February 28, 2023
Business Services

Ascelia Pharma AB (publ) (ticker: ACE), a biotech focused on improving the life of people living with rare cancer conditions, …

News
Press release

Johnson & Johnson’s Janssen-Cilag unit gets disappointing ‘restricted’ label for PARP drug in EU

February 28, 2023
Medical Communications

Johnson & Johnson (J&J)’s Janssen-Cilag unit has announced that its fixed-dose combination drug Akeega has been recommended for approval by …

News

Moderna to pay $400m to US government over new COVID-19 vaccine license

February 28, 2023
Sales and Marketing

Moderna, a leader in the development of COVID-19 vaccines, announced that it has paid the National Institute of Allergy and …

News

CSL receives positive results from rare disease drug phase 3 trial

February 28, 2023
Research and Development

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …

News

MHRA’s authority restored following Northern Ireland Brexit deal

February 28, 2023
Medical Communications

The Medicines and Healthcare products Regulatory Agency (MHRA) has been limited to approving medicines in Great Britain (England, Scotland and …

News

Rare and orphan disease expert Terebellum launches market access guide

February 28, 2023
Business Services

Terebellum, subsidiary of global specialty pharmacy and healthcare solutions organisation AscellaHealth, is launching a strategic guide to help manufacturers bring …

News
Press release

Rare disease community call for their unified voice to be heard in the fight for equitable care

February 28, 2023
Business Services

Reading, 28th February 2023.

News
Press release

PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)

February 27, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026